209 related articles for article (PubMed ID: 22257704)
1. Systematic review and meta-analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutropenic episodes in children and young people with cancer.
Phillips RS; Wade R; Lehrnbecher T; Stewart LA; Sutton AJ
BMC Med; 2012 Jan; 10():6. PubMed ID: 22257704
[TBL] [Abstract][Full Text] [Related]
2. An updated systematic review and meta-analysis of the predictive value of serum biomarkers in the assessment of fever during neutropenia in children with cancer.
Haeusler GM; Carlesse F; Phillips RS
Pediatr Infect Dis J; 2013 Oct; 32(10):e390-6. PubMed ID: 23673421
[TBL] [Abstract][Full Text] [Related]
3. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy.
Abrahamsson J; Påhlman M; Mellander L
Acta Paediatr; 1997 Oct; 86(10):1059-64. PubMed ID: 9350884
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.
Phillips B; Wade R; Stewart LA; Sutton AJ
Eur J Cancer; 2010 Nov; 46(16):2950-64. PubMed ID: 20621468
[TBL] [Abstract][Full Text] [Related]
8. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
Santolaya ME; Cofre J; Beresi V
Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
[TBL] [Abstract][Full Text] [Related]
10. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
[TBL] [Abstract][Full Text] [Related]
12. Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with fever and neutropenia.
Phillips B
F1000Res; 2021; 10():1070. PubMed ID: 35211295
[TBL] [Abstract][Full Text] [Related]
13. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
14. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
[TBL] [Abstract][Full Text] [Related]
15. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia.
Hatzistilianou M; Rekliti A; Athanassiadou F; Catriu D
Inflamm Res; 2010 May; 59(5):339-47. PubMed ID: 19806318
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
Urbonas V; Eidukaitė A; Tamulienė I
Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
[TBL] [Abstract][Full Text] [Related]
18. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
[TBL] [Abstract][Full Text] [Related]
19. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia.
Phillips RS; Lehrnbecher T; Alexander S; Sung L
PLoS One; 2012; 7(5):e38300. PubMed ID: 22693615
[TBL] [Abstract][Full Text] [Related]
20. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia.
Persson L; Söderquist B; Engervall P; Vikerfors T; Hansson LO; Tidefelt U
Eur J Haematol; 2005 Apr; 74(4):297-303. PubMed ID: 15777341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
